DRIO · Insider Trading
DarioHealth Corp. Common Stock
Every open-market purchase and sale reported by DRIO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-28 | John R Palumbo | Director | A | +62,000 | — |
| 2026-09-28 | Dennis M McGrath | Director | A | +61,000 | — |
| 2026-09-28 | Dennis Matheis | Director | A | +44,000 | — |
| 2026-09-28 | Hila Karah | Director | A | +28,000 | — |
| 2026-09-28 | Chen Franco-Yehuda | Chief Financial Officer | A | +95,000 | — |
| 2026-09-28 | Yoav Shaked | Director | MIXED | +54,772 | +$14.75K |
| 2026-09-28 | Adam K Stern | Director | MIXED | +48,195 | +$615.12K |
| 2026-09-28 | Erez Raphael | Chief Executive Officer | MIXED | +297,579 | +$11.06K |
| 2026-07-28 | Dennis Matheis | Director | MIXED | +15,395 | +$118.43K |
| 2025-09-15 | Dennis M McGrath | Director | A | +20,000 | — |
| 2025-09-15 | Hila Karah | Director | A | +20,000 | — |
| 2025-09-15 | Dennis Matheis | Director | A | +20,000 | — |
| 2025-09-15 | Yoav Shaked | Director | A | +20,000 | — |
| 2025-09-15 | Steven Charles Nelson | President and CCO | A | +30,000 | — |
| 2025-09-15 | Chen Franco-Yehuda | Chief Financial Officer | A | +5,000 | — |
| 2025-09-15 | Adam K Stern | Director | A | +20,000 | — |
| 2025-09-15 | Lawrence B. Leisure | Director | A | +20,000 | — |
| 2025-09-15 | Erez Raphael | Chief Executive Officer | A | +60,000 | — |
| 2025-08-27 | Steven Charles Nelson | President and CCO | Buy | +40,000 | +$21.20K |
| 2025-05-15 | Chen Franco-Yehuda | Chief Financial Officer | A | +500,000 | — |
| 2025-02-25 | Jon H. Kaplan | Director | A | +30,000 | — |
| 2025-01-10 | Adam K Stern | Director | Buy | — | — |
| 2024-11-14 | Steven Charles Nelson | Chief Commercial Officer | Buy | +5,000 | +$4.55K |
| 2024-09-12 | Steven Charles Nelson | Chief Commercial Officer | Buy | +10,000 | +$8.24K |
| 2024-09-10 | Steven Charles Nelson | Chief Commercial Officer | Buy | +15,000 | +$12.29K |
| 2024-08-28 | Erez Raphael | Chief Executive Officer | Buy | +5,000 | +$4.40K |
| 2024-08-23 | Steven Charles Nelson | Chief Commercial Officer | Buy | +15,000 | +$14.15K |
| 2024-08-23 | Erez Raphael | Chief Executive Officer | Buy | +10,000 | +$9.40K |
| 2024-08-20 | Erez Raphael | Chief Executive Officer | Buy | +10,000 | +$8.98K |
| 2024-08-20 | Steven Charles Nelson | Chief Commercial Officer | Buy | +10,000 | +$9.28K |
| 2024-06-07 | Steven Charles Nelson | Chief Commercial Officer | A | +2,100,000 deriv. | — |
| 2024-03-08 | Dennis Matheis | Director | A | +70,000 | — |
| 2024-03-08 | Hila Karah | Director | A | +70,000 | — |
| 2024-03-08 | Zvi Ben-David | Chief Financial Officer | A | +400,000 | — |
| 2024-03-08 | Yoav Shaked | Director | A | +90,000 | — |
| 2024-03-08 | Erez Raphael | Chief Executive Officer | A | +800,000 | — |
| 2024-03-08 | Jon H. Kaplan | Director | A | +70,000 | — |
| 2024-03-08 | Adam K Stern | Director | A | +70,000 | — |
| 2024-03-08 | Richard Alan Anderson | President | A | +1,070,000 deriv. | — |
| 2024-03-08 | Dennis M McGrath | Director | A | +80,000 | — |
| 2024-03-01 | Adam K Stern | Director | A | +250 deriv. | — |
| 2024-02-21 | Tomer Ben-Kiki | Chief Operating Officer | A | +1,017,947 deriv. | — |
| 2023-05-08 | Erez Raphael | Chief Executive Officer | Buy | — | — |
| 2023-05-08 | Jon H. Kaplan | Director | Buy | +30 deriv. | — |
| 2023-05-08 | Dennis Matheis | Director | Buy | — | — |
| 2023-05-08 | Yoav Shaked | Director | Buy | — | — |
| 2023-01-18 | Erez Raphael | Chief Executive Officer | Sell | −1,200 | −$7.45K |
| 2022-12-23 | Dennis M McGrath | Director | Sell | −9,872 | −$39.21K |
| 2022-06-10 | Richard Alan Anderson | President, GM of North America | D | −17,957 | — |
| 2022-05-20 | Dennis M McGrath | Director | A | +55,000 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Erez Raphael | Chief Executive Officer | 159,326 | $541.71K |
| Chen Franco-Yehuda | Chief Financial Officer | 125,000 | $425.00K |
| Dennis M McGrath | Director | 88,737 | $301.71K |
| Dennis Matheis | Director | 87,026 | $295.89K |
| Adam K Stern | Director | 75,623 | $257.12K |
| John R Palumbo | Director | 66,500 | $226.10K |
| Hila Karah | Director | 58,965 | $200.48K |
| Steven Charles Nelson | President and CCO | 34,750 | $118.15K |
| Yoav Shaked | Director | 33,666 | $114.46K |
| Lawrence B. Leisure | Director | 32,900 | $111.86K |
| Jon H. Kaplan | Director | 5,579 | $18.97K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DRIO quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.